Please provide your email address to receive an email when new articles are posted on . Kim’s hypothesis arises partially from studies that showed that C3, when introduced to synthetic neutrophils, ...
And this first part is going to focus on the mouse model and the translational research that kind of started giving us a pretty major clue of how the complements involve, what pathways involve, and ...
Dianthus achieved its NASDAQ listing last year via a merger with Magenta Therapeutics. The company is focused on development of a single drug candidate, DNTH-103, which targets the complement system, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results